Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Nurix Therapeutics Inc (NRIX)

Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Nurix Therapeutics Receives PRIME Designation from the European Medicines Agency for NX-5948 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia GlobeNewswire - Wed Nov 20, 3:00PM CST

NRIX : 22.05 (-1.43%)
Nurix Therapeutics Presents Preclinical Data on NX-5948 and GS-6791 at ACR Convergence 2024 Quiver Quantitative, Inc. - Sun Nov 17, 7:44PM CST

Nurix Therapeutics presented preclinical data on NX-5948 and GS-6791 at ACR Convergence 2024, highlighting their potential in treating inflammatory diseases.Quiver AI SummaryNurix Therapeutics, Inc. has...

NRIX : 22.05 (-1.43%)
Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024 GlobeNewswire - Sun Nov 17, 9:30AM CST

NRIX : 22.05 (-1.43%)
Nurix Therapeutics Announces Presentations at the 66th American Society of Hematology (ASH) Annual Meeting GlobeNewswire - Tue Nov 5, 8:00AM CST

NRIX : 22.05 (-1.43%)
Nurix Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire - Thu Oct 31, 6:00AM CDT

NRIX : 22.05 (-1.43%)
Nurix Therapeutics Announces Presentations at the 7th Annual TPD & Induced Proximity Summit GlobeNewswire - Mon Oct 21, 3:00PM CDT

NRIX : 22.05 (-1.43%)
Nurix Therapeutics Presents Positive Results from the Ongoing Clinical Trial of Its BTK Degrader NX-5948 in Patients with Relapsed/Refractory Waldenstrom’s Macroglobulinemia GlobeNewswire - Sat Oct 19, 7:00AM CDT

NRIX : 22.05 (-1.43%)
Nurix Therapeutics Expands Its Board of Directors with the Addition of Drug Commercialization Expert Anil Kapur GlobeNewswire - Wed Oct 16, 3:35PM CDT

NRIX : 22.05 (-1.43%)
Nurix Therapeutics Reports Third Quarter Fiscal 2024 Financial Results and Provides a Corporate Update GlobeNewswire - Fri Oct 11, 3:00PM CDT

NRIX : 22.05 (-1.43%)
Nurix Therapeutics Announces Presentations at ACR Convergence 2024, the Annual Meeting of the American College of Rheumatology GlobeNewswire - Wed Oct 9, 6:00AM CDT

NRIX : 22.05 (-1.43%)

Barchart Exclusives

How to Invest for Kids: Understanding the Basics Barchart - Sat Nov 23, 1:30PM CST
A good way to show kids the value of compounding money is to ask if they’d rather have a $100 bill today or a penny that doubles every day for 30 days. They will be surprised to hear that in 30 days, that penny would be worth about $5.4 million dollars! Here's a guide to the types of accounts you can open for your children or grandchildren. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot